Clinical Trial Update: Triple Negative Breast Cancer and Celecoxib. Pilot Study [Phase 2]

View source ↗

Summary

This is a Phase 2 pilot clinical trial evaluating celecoxib in combination for triple-negative breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Triple-Negative Breast Cancer | Phase 2 | Status: RECRUITING